Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: A study from North India

Archives of Toxicology

Volumn 78, Issue 8, 2004, Pages 430-434

  Srivastava, Daya Shankar Lal ^a   Kumar, Anant ^a   Mittal, Balraj ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bladder cancer; Genetic polymorphism; Glutathione S transferase; Multiplex PCR; Null genotype

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; STATISTICAL ANALYSIS; TOBACCO;

ADULT; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DNA; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX CHARACTERISTICS; SMOKING; URINARY BLADDER NEOPLASMS;

NICOTIANA TABACUM;

EID: 4544287707     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-004-0559-y     Document Type: Article

References (34)

1. Abdel-Rahman SZ, Anwar WA, Abdel-Aal, Mostafa HM, Au WW (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129-138
2. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolizing gene glutathione S-transferase M1 that increases susceptibility to bladder cancer. J Natl Cancer Inst 85:1159-1164
3. Brockmoller J, Kerb R, Drakoulis N, Staffeldt B, Roots I (1994) glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case control study. Cancer Res 54:4103-4111
4. Brockmoller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphism in arylamine N-acetyltransferases, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and CYP 450 enzyme as modulator of bladder cancer risk. Cancer Res 56:3915-3925
5. Buch SC, Notani PN, Bhisey RA (2002) Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23:803-807
6. Georgiou I, Filiadis IF, Alamanos Y, Bouba I, et al. (2000) Glutathione S-transferase null genotypes in transitional bladder cancer: a case control study. Eur Urol 37:660-664
7. Golka K, Reckwitz T, Kempkes M, Cascorbi II, Blaszkewicz M, Reich SE, Roots II, Soekeland J, Schulze H, Bolt HM. (1997) N-Acetyltransferase 2 (NAT2) and glutathione S-transferase M1 in bladder cancer patients in a highly industrialized area. Int J Occup Environ Health 3:105-110
8. Guengerich FP, Thier R, Persmark M, Taylor JB, Pemble SE, Ketterer B (1995) Conjugation of carcinogen by theta class glutathione S-transferase; mechanism and relevance to variations in human risk. Pharmacogenetics 5:S103-S107
9. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen K, Vainio H (1994) Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815
10. Katoh T, Inatomi H, Kim H, Yong M, Matsumoto T, Kawamoto T (1998) Effect of glutathione S-transferase GSTM1 and GSTT1 null genotypes in urothelial cancer risk. Cancer Lett 132:147-152
11. Kempkes M, Golka K, Reich S, Reckwitz T, Bolt HM (1996) Glutathione S-transferase M1 and T1 null genotype as potential risk factor for urothelial cancer of the bladder. Arch Toxicol 71:123-26
12. Ketterer B, Harris JM, Talaska G, et al. (1992) The human glutathione S-transferase supergene family; its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98:87-94
13. Kim H, Kim W-J, Lee H-L, et al. (1998) A case control study on the effects of the genetic polymorphisms of N-acetyltransferase 2 and glutathione S-transferase M1 and T1 on the risk of bladder cancer. Korean J Prev Med 31:275-284
14. Kim WJ, Lee HL, Lee SC, Kim YT, Kim H (2000) Polymorphism of N-acetyltransferase 2, glutathione S-transferase M1 and T1 genes as risk factor of bladder cancer in relation to asthma and tuberculosis. J Urol 164:209-213
15. Kim WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM, Lee HM, Katoh T (2002) GSTT1-null genotypes is a protective factor against bladder cancer. Urology 60:913-918
16. Lee SJ, Kang D, Cho SH, Kim SU, Park MS, Choi HY, Choi H (1999) Association of genetic polymorphism of glutathione S-transferase M1 and T1 and bladder cancer. J Korean Cancer Assoc 31:548-555
17. Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S (1994) Ethnic distribution of glutathione S-transferase mu null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis 15:1077-1081
18. Ma QW, Lin GF, Chen JG, Shen JH (2002) Polymorphism of glutathione S-transferase T1, M1 and P1 genes in Shanghai population: patients with occupational bladder cancer. Biomed Environ Sci 15:253-260
19. Mannervik B (1985) The isozymes of glutathione S-transferases. Adv Enzymol 57:357-417
20. Nair UJ, Nair J, Mathew B, Bartsch H (1999) Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian beta1 quid/tobacco chewers. Carcinogenesis 20:743-748
21. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300:271-276
22. Perera FP (1997) Environment and cancer: who are susceptible? Science 278:1068-1073
23. Roy B, Chowdhury A, Kundu S, Santra A, Dey B, Chakraborty M, Majumder PP (2001) Increased risk of antituberculosis drug induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation. J Gastroenterol Hepatol 16:1033-1037
24. Salagovic J, Kalina I, Stubna J, Habalova V, Hrivnak M, Vlansky L, Kohat A, Biros E (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 as risk factor in lung and bladder cancer. Neoplasma 45:312-317
25. Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning - a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY
26. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A (1993) Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 53:3486-3492
27. Silverman DT, Rothman N, Devesa SS (1999) Epidemiology of bladder cancer In: Syrigos KN, Skinner DG (eds) Bladder cancer. Biology, diagnosis, management. Oxford University Press, New York, pp 11-55
28. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR (2001) Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37:593-598
29. Strange RC Jones PW, and Fryer AA (2000) Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 112-113:357-363
30. Vineis P, Simonato L (1991) Proportion of lung and bladder cancers in males resulting from occupation. Arch Environ Health 46:6-15
31. Weber WW (1997) Human drug metabolizing enzyme variants. In: Roberts Frazare JA, Carter CO (eds) Pharmacogenetics. Oxford University Press, London, pp204-210
32. Wiencke JK, Kelsey KT, Lamella RA, Toscano WA (1990) Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide induced cytogenetic damage. Cancer Res 50:1585-1590
33. Wiencke JK, Pemble S, Ketterer B, Kelsey KT (1995) Gene deletion of glutathione S-transferase theta 1: Correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4:253-259
34. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14:1821-1824